In accordance with ASX Listing Rule 17.2 the Company provides the following information regarding the request:
1. The reason for the request of the voluntary suspension is to allow the ASX to complete its review of the terms in respect of a material commercial transaction with a Canadian cannabis company for MGC Derma.
2. The Company expects the voluntary suspension to end no later than the commencement of trade on Thursday, 27th September 2018, when it anticipates it will be in a position to make an announcement to the market in respect of the abovementioned matter.
3. The Company is not aware of any reason why the voluntary suspension should not be granted, nor of any other information necessary to inform the market about the voluntary suspension.
MXC Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
